Many Breast Cancer Survivors With Indications for Genetic Testing Do Not Receive It

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, July 23, 2024 -- Many breast cancer survivors with indications for genetic counseling and testing do not receive it, according to a study published online July 15 in the Journal of Clinical Oncology.

Steven J. Katz, M.D., from the University of Michigan in Ann Arbor, and colleagues examined receipt of genetic testing and communication with relatives about results into survivorship after diagnosis of breast cancer. Analysis included 1,412 women (aged 20 to 79 years) diagnosed with early-stage breast cancer in 2014 or 2015 who completed surveys approximately seven months and six years after diagnosis.

The researchers found that 47.4 percent had indications for genetic testing at any time (28.0 percent at baseline and 19.4 percent at the time of follow-up only). Just over seven in 10 with a baseline indication reported genetic testing (71.9 percent), compared to 53.3 percent with an indication at follow-up only and 35.0 percent with no indication. When controlling for age and clinical indications, there were no significant racial or ethnic differences in receipt of testing or genetic counseling. Women receiving genetic testing with a reported pathogenic variant (62 women) were much more likely to have talked to most or all their first-degree adult relatives about genetic testing, compared to those with a variant of unknown significance (49 women) or a negative finding (419 women; 62.7 percent versus 38.8 and 38.0 percent, respectively).

"Our findings reinforce the need for novel approaches to genetic risk evaluation and testing in practice to target prevention and early detection strategies for their patients and their families," senior author Allison Kurian, M.D., from Stanford University in California, said in a statement.

Two authors disclosed ties to the biotechnology and pharmaceutical industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-24 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords